Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
boston blog main
life sciences
national blog main
new york blog main
new york top stories
7
×
boston top stories
national top stories
clinical trials
fda
san francisco blog main
san francisco top stories
startups
biogen
boston
cancer
deals
ipo
novartis
sanofi
venture capital
alnylam pharmaceuticals
blackstone group
boulder/denver blog main
boulder/denver top stories
david goldstein
deerfield management
depression
detroit blog main
detroit top stories
drug discovery
epilepsy
essential tremor
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
investing
kiran reddy
What
medicines
7
×
new
drugs
ipo
research
aims
bio
ceo
covid
deal
developing
fda
praxis
precision
roundup
acquire
acquisitions
activity
agreed
announced
approach
approvals
backed
based
billion
biogen
biotech
biotechs
brings
called
cash
cause
central
cholesterol
clamped
cns
collabs
company
company’s
compound
Language
unset
7
×
Current search:
medicines
×
biotech
×
" new york top stories "
×
unset
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further